Lumos Pharma’s Patient-Centric Strategy for Rare Disease Drug Development
XTalks
JANUARY 23, 2024
Pediatric growth hormone deficiency (PGHD) is one such condition, affecting a child’s growth and development. This rare endocrine disorder, characterized by inadequate secretion of growth hormone from the pituitary gland, has profound impacts on physical and sometimes cognitive development.
72 
Let's personalize your content